A Comprehensive Analysis of Serum and Urine Bile Acid Profiles in Chronic Kidney Disease: An Exploratory Study of Clinical Associations
Nephrology · 2026-01 · 31 (1)
DOI: 10.1111/nep.70156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology, online erschienen am 06.01.2026. Verfasst von Takeo Koshida und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Bile Acids and Salts, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Aim
Dysbiosis contributes to systemic inflammation and the accumulation of uremic toxins, leading to end‐stage kidney disease. However, the role of bile acids (BAs), key metabolic products of the gut microbiota, in the pathophysiology of chronic kidney disease (CKD) remains incompletely understood. Profiling BA metabolism may provide valuable insights into CKD pathophysiology and help in identifying novel therapeutic targets.
Methods
This cross‐sectional study recruited 29 patients with advanced CKD and 30 sex‐ and age‐matched individuals with normal renal function (NRF). Serum and urine BA profiles were compared between the two groups.
Results
Total BA levels in serum did not differ significantly between the CKD and NRF groups. However, patients with CKD exhibited lower serum levels of unconjugated BAs and significantly higher levels of sulfate‐conjugated BAs than those with NRF. In contrast, urinary total BA levels and most BA subgroups were significantly lower in patients with CKD. Additionally, the serum levels of ursodeoxycholic, chenodeoxycholic acid and sulfated‐conjugated BAs were associated with a decline in the estimated glomerular filtration rate, even after adjusting for demographic factors and diabetes status.
Conclusion
This study provides a comprehensive analysis of serum and urinary BAs in patients with advanced CKD. Our findings highlight the association between specific BAs and CKD, suggesting a distinct pathophysiological role of BA metabolism in CKD progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan.
- Junshin Clinic Bile Acid Institute, Tokyo, Japan.
- Probiotics Research Laboratory, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
ORCID-Profile: Maki Murakoshi, Tomohito Gohda
Förderung
- JSPS KAKENHI
Zitieren
APA
Koshida, T., Nittono, H., Takei, H., Murakoshi, M., Yamashiro, Y., Suzuki, Y., & Gohda, T. (2026). A Comprehensive Analysis of Serum and Urine Bile Acid Profiles in Chronic Kidney Disease: An Exploratory Study of Clinical Associations. Nephrology, 31(1). https://doi.org/10.1111/nep.70156
Vancouver
Koshida T, Nittono H, Takei H, Murakoshi M, Yamashiro Y, Suzuki Y, et al. A Comprehensive Analysis of Serum and Urine Bile Acid Profiles in Chronic Kidney Disease: An Exploratory Study of Clinical Associations. Nephrology. 2026;31(1). doi:10.1111/nep.70156
BibTeX
@article{Koshida2026,
author = {Koshida, Takeo and Nittono, Hiroshi and Takei, Hajime and Murakoshi, Maki and Yamashiro, Yuichiro and Suzuki, Yusuke and Gohda, Tomohito},
title = {A Comprehensive Analysis of Serum and Urine Bile Acid Profiles in Chronic Kidney Disease: An Exploratory Study of Clinical Associations},
journal = {Nephrology},
year = {2026},
volume = {31},
number = {1},
doi = {10.1111/nep.70156}
}
EUVIMED